Abstract:To study the physicochemical properties of the DTTA chelating moiety (H4DTTA = diethylenetriaminetetraacetic acid = N,N'-[iminobis(ethane-2,1-diyl)]bis[N-(carboxymethyl)glycine]), used in several compounds proposed as magnetic resonance imaging (MRI) contrast agents, the methylated derivative H4DTTA-Me (N,N'-[(methylimino)bis(ethane-2,1-diyl)]bis[N-(carboxymethyl)glycine]) was synthesized. Protonation constants of the ligand were determined in an aqueous solution by potentimetry and (1)H NMR pH titration and compared to various DTTA derivatives. Stability constants were measured for the chelates formed with Gd(3+) (log K(GdL) = 18.60 +/- 0.10) and Zn(2+) (log K(ZnL) = 17.69 +/- 0.10). A novel approach of determining the relative conditional stability constant of two paramagnetic complexes in a direct way by (1)H NMR relaxometry is presented and was used for the Gd(3+) complexes [Gd(DTTA-Me)(H2O)2](-) (L1) and [Gd(DTPA-BMA)(H2O)] (L2) [K(L1/L2)*(at pH 8.3, 25 degrees C) = 6.4 +/- 0.3]. The transmetalation reaction of the Gd(3+) complex with Zn(2+) in a phosphate buffer solution (pH 7.0) was measured to be twice as fast for [Gd(DTTA-Me)(H2O)2](-) in comparison to that for [Gd(DTPA-BMA)(H2O)]. This can be rationalized by the higher affinity of Zn(2+) toward DTTA-Me(4-) if compared to DTPA-BMA(3-). The formation of a ternary complex with L-lactate, which is common for DO3A-based heptadentate complexes, has not been observed for [Gd(DTTA-Me)(H2O)2](-) as monitored by (1)H NMR relaxometric titrations. From the results, it was concluded that the heptadentate DTTA-Me(4-) behaves similarly to the commercial octadentate DTPA-BMA(3-) with respect to stability. The use of [Gd(DTTA-Me)(H2O)2](-) as an MRI contrast agent in vitro and in animal studies is conceivable, mainly at high magnetic fields, where an increase of the inner-sphere-coordination water actually seems to be the most certain way to increase the relaxivity.

Synthesis and Evaluation of Neutral Gd(III), Mn(II) Complexes from DTPA-Bisamide Derivative As Potential MRI Contrast Agents

Nmr Studies of Gd(Dtpa-Bin) in Human Serum Albumin Solution

Synthesis and T1-relaxation enhancement of neutral oligomeric manganese(II) complexes as MRI contrast agents

Synthesis and Evaluation of Aromatic Dtpa-Bis(Amide) Gadolinium Complexes As Magnetic Resonance Imaging Contrast Agents

Synthesis neutral rare earth complexes of diethylenetriamine-N,N''-bis(acetyl-isoniazid)-N,N',N''-triacetic acid as potential contrast enhancement agents for magnetic resonance imaging.

Synthesis and preliminary evaluation of gadolinium complexes containing sulfonamide groups as potential MRI contrast agents

Synthesis of a Highly Stable Gadolinium Based MRI Contrast Agent

Synthesis And Evaluation Of A High Relaxivity Manganese(Ii)-Based Mri Contrast Agent

Comparison Between Gd-Dtpa and Several Bisamide Derivatives As Potential Mri Contrast Agents

Physicochemical properties of the high-field MRI-relevant [Gd(DTTA-Me)(H2O)2]- complex

Synthesis, thermodynamics stability constant and relaxation properties of neutral Gd(III) complex with derivative from diethylene triamine pentaacetic acid and p-hydroxybenzoyl hydrazine.

Synthesis, Relaxivity and MRI Enhancement of Linear Oligo‐Gd(III) Complexes with Poly (dtpa‐ester) Ligands Derived from Amino Acids

Multinuclear Mn(II) United-Dota Complexes with Enhanced Inertness and High MRI Contrast Ability

Synthesis and Relaxivity of Gd(III), Fe(III) and Mn(II) Complexes with Dihydropyridine Derivative of Diethylenetriaminepentaacetic Acid

The Development of Dendritic Gd-Dtpa Complexes for Mri Contrast Agents

Synthesis and relaxation properties of lanthanide(Gd,Yb) complexes with tris modified DTPA

Application of Gd(III) Complexes for Magnetic Resonance Imaging and the Improvement of Relaxivities Via Nanocrystallization

Modified DTPA, EDTA Ligands and Their Paramagnetic Metal Complexes As Contrast Agents for MRI

Synthesis and Characterization of Amphiphilic Gd(III) Complexes: Gd‐DTPA‐BA

Gadolinium(III) Chelated Conjugated Polymer As a Potential MRI Contrast Agent

The gadolinium complexes with polyoxometalates as potential MRI contrast agents.